JP2015511952A5 - - Google Patents

Download PDF

Info

Publication number
JP2015511952A5
JP2015511952A5 JP2014559259A JP2014559259A JP2015511952A5 JP 2015511952 A5 JP2015511952 A5 JP 2015511952A5 JP 2014559259 A JP2014559259 A JP 2014559259A JP 2014559259 A JP2014559259 A JP 2014559259A JP 2015511952 A5 JP2015511952 A5 JP 2015511952A5
Authority
JP
Japan
Prior art keywords
triazine
isopropyl
pyrazolo
amine
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014559259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015511952A (ja
JP6182549B2 (ja
Filing date
Publication date
Priority claimed from EP12157751.4A external-priority patent/EP2634190A1/en
Application filed filed Critical
Publication of JP2015511952A publication Critical patent/JP2015511952A/ja
Publication of JP2015511952A5 publication Critical patent/JP2015511952A5/ja
Application granted granted Critical
Publication of JP6182549B2 publication Critical patent/JP6182549B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014559259A 2012-03-01 2013-03-01 選択的サイクリン依存性キナーゼ阻害剤としてのピラゾロ−トリアジン誘導体 Active JP6182549B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12157751.4 2012-03-01
EP12157751.4A EP2634190A1 (en) 2012-03-01 2012-03-01 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors
PCT/EP2013/054224 WO2013128028A1 (en) 2012-03-01 2013-03-01 Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors

Publications (3)

Publication Number Publication Date
JP2015511952A JP2015511952A (ja) 2015-04-23
JP2015511952A5 true JP2015511952A5 (enExample) 2017-08-03
JP6182549B2 JP6182549B2 (ja) 2017-08-16

Family

ID=47757629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014559259A Active JP6182549B2 (ja) 2012-03-01 2013-03-01 選択的サイクリン依存性キナーゼ阻害剤としてのピラゾロ−トリアジン誘導体

Country Status (17)

Country Link
US (1) US9567345B2 (enExample)
EP (2) EP2634190A1 (enExample)
JP (1) JP6182549B2 (enExample)
KR (1) KR101821452B1 (enExample)
CN (1) CN104350054B (enExample)
AU (1) AU2013224848B2 (enExample)
BR (1) BR112014021189B1 (enExample)
CA (1) CA2865946C (enExample)
DK (1) DK2820020T3 (enExample)
ES (1) ES2583231T3 (enExample)
HU (1) HUE029264T2 (enExample)
IL (1) IL234183A (enExample)
MX (1) MX347359B (enExample)
RU (1) RU2645347C2 (enExample)
SG (1) SG11201405129RA (enExample)
WO (1) WO2013128028A1 (enExample)
ZA (1) ZA201406078B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201403093D0 (en) 2014-02-21 2014-04-09 Cancer Rec Tech Ltd Therapeutic compounds and their use
WO2015154038A1 (en) 2014-04-04 2015-10-08 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
EP3805218A1 (en) * 2014-04-05 2021-04-14 Syros Pharmaceuticals, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
EP3214086B1 (en) 2014-10-31 2021-09-22 Ube Industries, Ltd. Substituted dihydropyrrolopyrazole compound
EP3268000B1 (en) * 2015-03-09 2021-08-04 Aurigene Discovery Technologies Limited Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
KR102588426B1 (ko) 2015-06-15 2023-10-13 유비이 가부시키가이샤 치환 디히드로피롤로피라졸 유도체
RU2712196C2 (ru) * 2015-06-24 2020-01-24 Куровир Аб Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии
HUE046449T2 (hu) 2016-09-13 2020-03-30 Allergan Inc Stabilizált, nem fehérje eredetû, clostridiális toxin készítmények
CN106432249B (zh) * 2016-09-30 2018-12-04 陕西科技大学 一类吡咯并[2,1-f][1,2,4]三嗪母核化合物的合成及其医药用途
WO2019032720A1 (en) 2017-08-09 2019-02-14 Sanford Burnham Prebys Medical Discovery Institute APELIN RECEPTOR AGONISTS AND METHODS OF USE
GB201715194D0 (en) 2017-09-20 2017-11-01 Carrick Therapeutics Ltd Compounds and their therapeutic use
UY38051A (es) * 2018-01-17 2019-08-30 Glaxosmithkline Ip Dev Ltd INHIBIDORES DE LA PI4KIIIß
CA3095880A1 (en) * 2018-04-11 2019-10-17 Qurient Co., Ltd. Pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives as selective inhibitor of cyclin dependent kinase
US11858937B2 (en) * 2018-04-11 2024-01-02 Qurient Co., Ltd. Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors
WO2020051689A1 (en) * 2018-09-12 2020-03-19 The Governing Council Of The University Of Toronto Compounds and methods for treating nematode infections
US11517568B2 (en) 2018-09-12 2022-12-06 The Governing Council Of The University Of Toronto Compounds and methods for treating nematode infections
CA3118324A1 (en) 2018-11-01 2020-05-07 Syros Pharmaceuticals, Inc. Methods of treating cancer in biomarker-identified patients with non-covalent inhibitors of cyclin-dependent kinase 7 (cdk7)
US12304913B2 (en) 2018-11-14 2025-05-20 Ube Industries, Ltd. Dihydropyrrolopyrazole derivative
CN110101703B (zh) * 2019-05-06 2021-06-11 暨南大学 Cdk7抑制剂在制备溃疡性结肠炎或结肠癌药物的应用
RU2713152C1 (ru) * 2019-08-30 2020-02-04 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения хронической аллергической крапивницы на фоне описторхоза
TW202146416A (zh) * 2019-12-11 2021-12-16 德商拜耳廠股份有限公司 吡唑并三𠯤
GB201918541D0 (en) 2019-12-16 2020-01-29 Carrick Therapeutics Ltd Therapeutic compounds and their use
CN110950871B (zh) * 2019-12-25 2022-05-17 陕西师范大学 2-取代-4-芳氨基吡唑并三嗪衍生物及制备抗肿瘤药物的应用
EP4263554A1 (en) * 2020-12-21 2023-10-25 JANSSEN Pharmaceutica NV Tricyclic pyrimidines as cyclin-dependent kinase 7 (cdk7) inhibitors
WO2022189387A1 (en) * 2021-03-09 2022-09-15 Janssen Pharmaceutica Nv Tricyclic pyridines as cyclin-dependent kinase 7 (cdk7) inhibitors
US20250042903A1 (en) * 2021-06-17 2025-02-06 H. Lee Moffitt Cancer Center And Research Institute, Inc. Triazine inhibitors of cyclin-dependent kinases
WO2023001061A1 (en) * 2021-07-17 2023-01-26 Jingrui Biopharma Co., Ltd. Cdk7 selective inhibitors as anticancer agents
AU2022318251A1 (en) 2021-07-29 2024-01-25 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
CN118284610A (zh) * 2021-11-23 2024-07-02 原真股份有限公司 用作cdk9抑制剂的吡唑并三嗪衍生物
CN114181217B (zh) * 2022-01-10 2022-12-27 陕西师范大学 吡唑并[1,5-a][1,3,5]三嗪衍生物及其盐和在制备抗癌药物中的应用
CA3245918A1 (en) * 2022-03-18 2023-09-21 Qurient Co., Ltd. CDK7 INHIBITORS FOR ANTIVIRAL TREATMENT
CN120712267A (zh) * 2023-02-21 2025-09-26 杭州德睿智药科技有限公司 作为CDKs抑制剂的新型并杂环类新化合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US615968A (en) 1898-12-13 Apparatus for treating ores
BR0007919A (pt) * 1999-02-01 2002-04-09 Cv Therapeutics Inc Composição purina 2,6,9-trisubstituìda
US7119200B2 (en) * 2002-09-04 2006-10-10 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PE20051128A1 (es) * 2004-02-25 2006-01-16 Schering Corp Pirazolotriazinas como inhibidores de quinasa
CZ302122B6 (cs) * 2009-01-28 2010-10-20 Univerzita Palackého v Olomouci Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující
FR2943058B1 (fr) * 2009-03-11 2011-06-03 Centre Nat Rech Scient Derives de pyrazolo°1,5-a!-1,3,5-triazines, leur preparation et leur application en therapeutique.
CZ302711B6 (cs) * 2009-06-03 2011-09-14 Univerzita Palackého v Olomouci Substituované deriváty 6-(2-hydroxybenzylamino)purinu, jejich použití jako léciva a farmaceutické prípravky tyto slouceniny obsahující

Similar Documents

Publication Publication Date Title
JP2015511952A5 (enExample)
AU2021236451B2 (en) P2X7 modulators
TWI762939B (zh) Btk抑制劑環衍生物及其製備方法和藥學上的應用
AU2019382642B2 (en) GLP-1R agonists and uses thereof
JP6182549B2 (ja) 選択的サイクリン依存性キナーゼ阻害剤としてのピラゾロ−トリアジン誘導体
TWI243820B (en) Pyrrolo[2,3-d]pyrimidine compounds and pharmaceutical composition containing the same
ES2294189T3 (es) Derivados de pirazolopirimidinona que tienen accion inhibidora de pde7.
AU2018237123B2 (en) Bruton's tyrosine kinase inhibitors
CA2754330A1 (en) Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
KR20070009699A (ko) 프롤린 유도체 및 그의 다이펩티딜 펩티다제-iv저해제로서의 용도
AU2006279525A1 (en) Monocyclic and bicyclic compounds and methods of use
EP3414234A1 (en) Bruton's tyrosine kinase inhibitors
MX2011004211A (es) Derivados de sulfonamido pirimidina y triazina como inhibidores de receptor de bradiquinina b1 (b1r) para tratamiento de dolor.
BR102015024618A2 (pt) compostos inibidores de quinase de ligação de tank
DK2969000T3 (en) NEW CONNECTIONS
FI94526C (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsol-2-yyli- ja imidatso/4,5-b/pyridin-2-yyli-amino- ja -metyyli-1-piperidinyylietyylijohdannaisten valmistamiseksi
KR20230051500A (ko) Alk5 억제제로서 피리다진일 아미노 유도체
WO2023154124A1 (en) Acylated heterocyclic quinazoline derivatives as inhibitors of erbb2
BR112021003652A2 (pt) novo derivado de amina heterocíclica e composição farmacêutica compreendendo o mesmo
KR20110028445A (ko) 퇴행성 및 염증성 질병의 치료에 유용한 축합된 피라진 화합물
JP2024534169A (ja) Egfr阻害剤としての置換アミノピリジン化合物
JP2025020216A (ja) Dnaポリメラーゼiiic阻害剤及びその使用
EP3827005B1 (en) Pyridopyrimidines as histamine h4-receptor inhibitors
ES2771151T3 (es) Derivados de piperidina como inhibidor de señalización wnt
Oboh Optimization of Triazolopyridazines and PI4k Inhibitors as Potential Treatments for Cryptosporidiosis